Cadherin-11 is inactivated due to promoter methylation and functions in colorectal cancer as a tumour suppressor

References

• Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;394–424. 30207593
   PubMed Web of Science ®Google Scholar
• Rabeneck L, Horton S, Zauber AG, Earle C. Colorectal cancer In: Cancer. Disease Control Priorities. 3rd ed. The International Bank for Reconstruction and Development / The World Bank Vol. 363 2015:101–116.
   Google Scholar
• Li L, Ying J, Li H, et al. The human cadherin 11 is a pro-apoptotic tumor suppressor modulating cell stemness through Wnt/beta-catenin signaling and silenced in common carcinomas. J Cell Sci. 2012;31(34):3901–3912.
   Google Scholar
• Margulis A, Zhang W, Alt-Holland A, Crawford HC, Fusenig NE, Garlick JA. E-cadherin suppression accelerates squamous cell carcinoma progression in three-dimensional, human tissue constructs. Cancer Res. 2005;65(5):1783–1791. doi:10.1158/0008-5472.CAN-04-339915753375
   PubMed Web of Science ®Google Scholar
• Andreeva AV, Kutuzov MA. Cadherin 13 in cancer. Genes Chromosomes Cancer. 2010;49(9):775–790. 20607704
   PubMed Web of Science ®Google Scholar
• Grady WM, Carethers JM. Genomic and epigenetic instability in colorectal cancer pathogenesis. Gastroenterology. 2008;135(4):1079–1099. doi:10.1053/j.gastro.2008.07.07618773902
   PubMed Web of Science ®Google Scholar
• Assefnia S, Dakshanamurthy S, Guidry Auvil JM, et al. Cadherin-11 in poor prognosis malignancies and rheumatoid arthritis: common target, common therapies. Oncotarget. 2014;5(6):1458–1474. doi:10.18632/oncotarget.153824681547
   PubMedGoogle Scholar
• Deng Z, Niu G, Cai L, Wei R, Zhao X. The prognostic significance of CD44V6, CDH11, and beta-catenin expression in patients with osteosarcoma. Biomed Res Int. 2013;2013:496193. doi:10.1155/2013/49619323971040
   PubMed Web of Science ®Google Scholar
• Yao J, Deng B, Zheng L, Dou L, Guo Y, Guo K. miR-27b is upregulated in cervical carcinogenesis and promotes cell growth and invasion by regulating CDH11 and epithelial-mesenchymal transition. Oncol Rep. 2016;35(3):1645–1651. doi:10.3892/or.2015.450026706910
   PubMed Web of Science ®Google Scholar
• Carmona FJ, Villanueva A, Vidal A, et al. Epigenetic disruption of cadherin-11 in human cancer metastasis. J Pathol. 2012;228(2):230–240. doi:10.1002/path.401122374749
   PubMed Web of Science ®Google Scholar
• Wang C, Yue Y, Shao B, et al. Dickkopf-related protein 2 is epigenetically inactivated and suppresses colorectal cancer growth and tumor metastasis by antagonizing Wnt/β-catenin signaling. Cell Physiol Biochem. 2017;41(5):1709–1724. doi:10.1159/00047186128365691
   PubMedGoogle Scholar
• Xiang S, Xiang T, Xiao Q, Li Y, Shao B, Luo T. Zinc-finger protein 545 is inactivated due to promoter methylation and functions as a tumor suppressor through the Wnt/beta-catenin, PI3K/AKT and MAPK/ERK signaling pathways in colorectal cancer. Int J Oncol. 2017;51(3):801–811. doi:10.3892/ijo.2017.406428677721
   PubMed Web of Science ®Google Scholar
• Tao Q, Huang H, Geiman TM, et al. Defective de novo methylation of viral and cellular DNA sequences in ICF syndrome cells. Hum Mol Genet. 2002;11(18):2091–2102. 12189161
   PubMed Web of Science ®Google Scholar
• Pei L, He X, Li S, et al. KRAB zinc-finger protein 382 regulates epithelial-mesenchymal transition and functions as a tumor suppressor, but is silenced by CpG methylation in gastric cancer. Int J Oncol. 2018. doi:10.3892/ijo.2018.4446
   Google Scholar
• Zhao L, Li S, Gan L, et al. Paired box 5 is a frequently methylated lung cancer tumour suppressor gene interfering beta-catenin signalling and GADD45G expression. J Cell Mol Med. 2016;20(5):842–854. doi:10.1111/jcmm.1276826843424
   PubMed Web of Science ®Google Scholar
• Li C, Tang L, Zhao L, et al. OPCML is frequently methylated in human colorectal cancer and its restored expression reverses EMT via downregulation of smad signaling. Am J Cancer Res. 2015;5(5):1635–1648. 26175934
   PubMed Web of Science ®Google Scholar
• Elshaer M, Chen Y, Wang XJ, Tang X. Resveratrol: an overview of its anti-cancer mechanisms. Life Sci. 2018;207:340–349. doi:10.1016/j.lfs.2018.06.02829959028
   PubMed Web of Science ®Google Scholar
• Hai Ping P, Feng BT, Li L, Nan Hui Y, Hong Z. IL-1beta/NF-kb signaling promotes colorectal cancer cell growth through miR-181a/PTEN axis. Arch Biochem Biophys. 2016;604:20–26. doi:10.1016/j.abb.2016.06.00127264420
   PubMed Web of Science ®Google Scholar
• Puvvada SD, Funkhouser WK, Greene K, et al. NF-kB and Bcl-3 activation are prognostic in metastatic colorectal cancer. Oncology. 2010;78(3–4):181–188. doi:10.1159/00031369720414006
   PubMed Web of Science ®Google Scholar
• De Simone V, Franze E, Ronchetti G, et al. Th17-type cytokines, IL-6 and TNF-alpha synergistically activate STAT3 and NF-kB to promote colorectal cancer cell growth. Oncogene. 2015;34(27):3493–3503. doi:10.1038/onc.2014.28625174402
   PubMed Web of Science ®Google Scholar
• Piao S, Inglehart RC, Scanlon CS, Russo N, Banerjee R, D’Silva NJ. CDH11 inhibits proliferation and invasion in head and neck cancer. J Oral Pathol Med. 2017;46(2):89–97. doi:10.1111/jop.1247127397103
   PubMed Web of Science ®Google Scholar
• Azarsina S, Otoukesh B, Taheriazam A, et al. Diagnostic investigations of PLA2G16 and CDH11 expression levels as independent prognostic markers of human osteosarcoma. Arch Med Sci. 2017;13(6):1347–1351. doi:10.5114/aoms.2016.5971029181064
   PubMed Web of Science ®Google Scholar
• Delic S, Lottmann N, Jetschke K, Reifenberger G, Riemenschneider MJ. Identification and functional validation of CDH11, PCSK6 and SH3GL3 as novel glioma invasion-associated candidate genes. Neuropathol Appl Neurobiol. 2012;38(2):201–212. doi:10.1111/j.1365-2990.2011.01207.x21722156
   PubMed Web of Science ®Google Scholar
• Bosserhoff AK, Ellmann L, Quast AS, Eberle J, Boyle GM, Kuphal S. Loss of T-cadherin (CDH-13) regulates AKT signaling and desensitizes cells to apoptosis in melanoma. Mol Carcinog. 2014;53(8):635–647. doi:10.1002/mc.2201823625515
   PubMed Web of Science ®Google Scholar
• Lin YL, Gui SL, Ma JG. Aberrant methylation of CDH11 predicts a poor outcome for patients with bladder cancer. Oncol Lett. 2015;10(2):647–652. doi:10.3892/ol.2015.333726622548
   PubMed Web of Science ®Google Scholar
• Zhang K, Zhaos J, Liu X, et al. Activation of NF-B upregulates Snail and consequent repression of E-cadherin in cholangiocarcinoma cell invasion. Hepato-gastroenterology. 2011;58(105):1–7. 21510277
   PubMedGoogle Scholar
• Jana A, Krett NL, Guzman G, et al. NFkB is essential for activin-induced colorectal cancer migration via upregulation of PI3K-MDM2 pathway. Oncotarget. 2017;8(23):37377–37393. doi:10.18632/oncotarget.1634328418896
   PubMedGoogle Scholar
• Wang S, Liu Z, Wang L, Zhang X. NF-kappaB signaling pathway, inflammation and colorectal cancer. Cell Mol Immunol. 2009;6(5):327–334. doi:10.1038/cmi.2009.4319887045
   PubMed Web of Science ®Google Scholar
• Voboril R, Weberova-Voborilova J. Constitutive NF-kappaB activity in colorectal cancer cells: impact on radiation-induced NF-kappaB activity, radiosensitivity, and apoptosis. Neoplasma. 2006;53(6):518–523. 17167722
   PubMed Web of Science ®Google Scholar
• Baldwin AS Jr. The NF-kappa B and I kappa B proteins: new discoveries and insights. Annu Rev Immunol. 1996;14:649–683. doi:10.1146/annurev.immunol.14.1.6498717528
   PubMed Web of Science ®Google Scholar
• Ghosh S, Karin M. Missing pieces in the NF-kappaB puzzle. Cell. 2002;109(Suppl):S81–96. 11983155
   PubMed Web of Science ®Google Scholar
• Hassanzadeh P. Colorectal cancer and NF-kappaB signaling pathway. Gastroenterol Hepatol Bed Bench. 2011;4(3):127–132. 24834170
   PubMedGoogle Scholar
• Hoffmann A, Baltimore D. Circuitry of nuclear factor kappaB signaling. Immunol Rev. 2006;210:171–186. doi:10.1111/j.0105-2896.2006.00375.x16623771
   PubMed Web of Science ®Google Scholar
• Deeb D, Gao X, Liu YB, Pindolia K, Gautam SC. Pristimerin, a quinonemethide triterpenoid, induces apoptosis in pancreatic cancer cells through the inhibition of pro-survival Akt/NF-κB/mTOR signaling proteins and anti-apoptotic Bcl-2. Int J Oncol. 2014;44(5):1707–1715. doi:10.3892/ijo.2014.232524603988
   PubMed Web of Science ®Google Scholar
• Ghaderian SB, Hayati F, Shayanpour S, Beladi Mousavi SS. Diabetes and end-stage renal disease; a review article on new concepts. J Renal Inj Prev. 2015;4(2):28–33. doi:10.12861/jrip.2015.0726060834
   PubMed Web of Science ®Google Scholar